Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2195 Views
-
Last post by frodo
-
- 0 Replies
- 10087 Views
-
Last post by NHE
-
- 2 Replies
- 1651 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1848 Views
-
Last post by Petr75
-
- 0 Replies
- 1230 Views
-
Last post by NHE
-
- 2 Replies
- 1882 Views
-
Last post by frodo
-
- 0 Replies
- 10884 Views
-
Last post by NHE
-
- 0 Replies
- 2526 Views
-
Last post by frodo
-
- 0 Replies
- 2683 Views
-
Last post by NHE